Clinical trial
Doxazosin as a Potential Treatment for Methamphetamine Dependence
NCT02785393 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Doxazosin as a Potential Treatment for Methamphetamine Dependence
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- March 31, 2016
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.